The tyramine binding site in the central nervous system: an overview (Q40857739)

24 September 2017

1 reference

title

The tyramine binding site in the central nervous system: an overview (English)

1 reference

24 September 2017

A Vaccari

1

1 reference

24 September 2017

1 August 1993

1 reference

24 September 2017

Neurochemical Research

1 reference

24 September 2017

18

1 reference

24 September 2017

8

1 reference

24 September 2017

861-868

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00998269

24 September 2017

0 references

cites work

High affinity binding of [3H]-tyramine in the central nervous system

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00998269

Interaction of 1-methyl-4-phenylpyridinium ion and tyramine with a site putatively involved in the striatal vesicular release of dopamine

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00998269

Biochemical mapping of the noradrenergic projection from the locus coeruleus. A model for studies of brain neuronal pathways

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00998269

Dopaminergic innervation and binding in the rat cerebellum

21 January 2018

1 reference

12 December 2020

Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles

1 reference

12 December 2020

In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine.

1 reference

12 December 2020

DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)—A useful denervation tool for central and peripheral noradrenaline neurons

1 reference

12 December 2020

1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities.

1 reference

12 December 2020

Conversion of biomembrane-produced energy into electric form. II. Intact mitochondria

1 reference

12 December 2020

A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons

1 reference

12 December 2020

Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport

1 reference

12 December 2020

[3H]Dihydrotetrabenazine binding to bovine striatal synaptic vesicles.

1 reference

12 December 2020

Characterization of a putatively vesicular binding site for [3H]MPP+ in mouse striatal membranes

1 reference

12 December 2020

Neonatal hypothyroidism induces striatal dopaminergic dysfunction

1 reference

12 December 2020

Mechanism of accumulation of the 1-methyl-4-phenylpyridinium species into mouse brain synaptosomes.

1 reference

12 December 2020

Potent, extra-channel influence of several calcium-channel modulators on striatal binding of [3H]tyramine.

1 reference

12 December 2020

Uptake of tyramine into synaptic vesicles of the caudate nucleus

1 reference

12 December 2020

The effect of calcium channel blockers on the H+-ATPase and bioenergetics of catecholamine storage vesicles

1 reference

12 December 2020

H(+)-ATPase, a primary pump for accumulation of neurotransmitters, is a major constituent of brain synaptic vesicles.

1 reference

12 December 2020

Differential interaction of 1-methyl-4-phenylpyridinium ion with the putatively vesicular binding site of [3H]tyramine in dopaminergic and nondopaminergic brain regions.

1 reference

12 December 2020

Enhancement by tetraphenylboron of inhibition of mitochondrial respiration induced by 1-methyl-4-phenylpyridinium ion (MPP(+))

1 reference

12 December 2020

The effect of prenylamine and organic nitrates on the bioenergetics of bovine catecholamine storage vesicles

1 reference

12 December 2020

MPP+-induced efflux of dopamine and lactate from rat striatum have similar time courses as shown by in vivo brain dialysis

1 reference

12 December 2020

Cloning and characterization of a Drosophila tyramine receptor.

1 reference

12 December 2020

[3H]mazindol binding associated with neuronal dopamine uptake sites in corpus striatum membranes.

1 reference

12 December 2020

A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter

1 reference

12 December 2020

Antidopaminergic action of verapamil and several other drugs: inactivation of vesicular dopamine

1 reference

12 December 2020

Kinetics of tyramine transport and permeation across chromaffin-vesicle membranes

1 reference

12 December 2020

[3H]tyramine binding: a comparison with neuronal [3H]dopamine uptake and [3H]mazindol binding processes

1 reference

12 December 2020

Uptake of dopamine into fractions of pig caudate nucleus homogenates

1 reference

12 December 2020

Kainic acid lesions of striatum and decortication reduce specific [3H]sulpiride binding in rats, so D-2 receptors exist post-synaptically on corticostriate afferents and striatal neurons

1 reference

12 December 2020

Release and receptor stimulating properties of p-tyramine in rat brain.

1 reference

12 December 2020

On the origin of dopamine and its metabolite in predominantly noradrenergic innervated brain areas.

1 reference

12 December 2020

Reserpine binding to chromaffin granules suggests the existence of two conformations of the monoamine transporter

1 reference

12 December 2020

Presence of 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, novel endogenous amines, in parkinsonian and normal human brains.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00998269

1 reference

PubMed ID

8396735

Dimensions Publication ID

24 September 2017

0 references

1 reference

PubMed ID

8396735